Home
Search

Policy

BIO advocates for laws, funding and other governmental actions that ensure that biotechnology companies are able to focus on their research to drive the future of innovation.

Press Releases
Browse all Press Releases
BIO Statement on Resignation of FDA Commissioner Marty Makary
May 12, 2026
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE changes, which included the firing of thousands of…
BIO Launches “The Fight of Our Lives,” a National Campaign to Spotlight the Impact of Biotechnology on the Lives of Patients and Families​​ ​
April 15, 2026
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them, and the scientists working to make them possible…
BIO Statement on the Section 232 Pharmaceutical Proclamation
April 2, 2026
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on Section 232 Pharmaceutical Proclamation.“A thriving American biotechnology ecosystem is essential to growing the U.S. economy, strengthening national…